A decade of combination chemotherapy of advanced Hodgkin's disease.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000477:Alkylating Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007109:Immunity / Q000187:drug effects; D008297:Male; D008727:Methotrexate; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D012075:Remission, Spontaneous; D013091:Spermatogenesis / Q000187:drug effects; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use; D014748:Vinca Alkaloids / Q000627:therapeutic use
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D014748:Vinca Alkaloids; D011344:Procarbazine; D014747:Vinblastine; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate